Quantamental Technologies LLC Corcept Therapeutics Inc Transaction History

Quantamental Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $171,670 - $250,621	9,906 New	9,906 $236,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $182,259 - $277,965	-11,026 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $188,544 - $257,346	11,026 New	11,026 $218,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $282,759 - $460,032	-16,851 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $209,963 - $336,682	16,851 New	16,851 $293,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $146,649 - $206,233	-12,160 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$10.41 - $14.66 $77,502 - $109,143	7,445 Added 157.9%	12,160 $172,000
Q2 2019 Aug 12, 2019	SELL	$9.78 - $12.76 $109,848 - $143,320	-11,232 Reduced 70.43%	4,715 $53,000
Q1 2019 Apr 29, 2019	BUY	$10.03 - $15.71 $150,219 - $235,288	14,977 Added 1544.02%	15,947 $187,000
Q4 2018 Jan 28, 2019	BUY	$11.29 - $17.19 $10,951 - $16,674	970 New	970 $13,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.